Women's health after plastic surgery

Area of Science:

• Plastic Surgery
• Rheumatology
• Immunology

Background:

• Concerns exist regarding silicone breast implants and connective tissue diseases.
• Previous studies suggested no increased risk.
• This study aimed to investigate autoimmune and connective tissue disorders in women with augmentation mammoplasty.

Purpose of the Study:

• To compare the prevalence of autoimmune and connective tissue disorders in women with and without augmentation mammoplasty.
• To assess the association between breast implants and various rheumatological conditions.
• To evaluate specific outcomes such as rheumatoid arthritis, lupus, and fibromyalgia.

Main Methods:

• Population-based retrospective cohort study comparing women with augmentation mammoplasty to those with other plastic surgeries.
• Matched cohorts for age, surgery year, and surgical team.
• Assessed a wide range of autoimmune, connective tissue, and other disorders, including antinuclear antibody (ANA) levels.

Main Results:

• No significant difference in connective tissue diseases, thyroid disorders, fibromyalgia, or multiple sclerosis between groups.
• Higher incidence of axillary adenopathy (OR=3.50) and low-titer ANA (OR=1.29) in the augmentation mammoplasty cohort.
• Axillary adenopathy correlated with capsular contracture and self-reported digital vasospasm.

Conclusions:

• Augmentation mammoplasty was not associated with an increased risk of connective tissue diseases.
• Increased frequency of axillary adenopathy and low-titer ANA observed in the exposed group.
• Axillary adenopathy linked to capsular contracture and digital vasospasm; low-titer ANA elevation considered of dubious clinical significance.